Next Article in Journal
Gray and White Matter Changes Associated with Psychophysical Functions Induced by Diabolo Training in Young Men
Next Article in Special Issue
Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response
Previous Article in Journal
Stereogram of the Living Heart, Lung, and Adjacent Structures
Previous Article in Special Issue
Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phantom Validation of a Conservation of Activity-Based Partial Volume Correction Method for Arterial Input Function in Dynamic PET Imaging

1
Quantitative Imaging for Personalized Cancer Medicine (QIPCM)—Techna Institute, University Health Network, Toronto, ON M5G 2C4, Canada
2
Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada
3
Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada
*
Author to whom correspondence should be addressed.
Tomography 2022, 8(2), 842-857; https://doi.org/10.3390/tomography8020069
Submission received: 15 January 2022 / Revised: 10 March 2022 / Accepted: 16 March 2022 / Published: 21 March 2022
(This article belongs to the Special Issue Quantitative Imaging Network)

Abstract

:
Dynamic PET (dPET) imaging can be utilized to perform kinetic modelling of various physiologic processes, which are exploited by the constantly expanding range of targeted radiopharmaceuticals. To date, dPET remains primarily in the research realm due to a number of technical challenges, not least of which is addressing partial volume effects (PVE) in the input function. We propose a series of equations for the correction of PVE in the input function and present the results of a validation study, based on a purpose built phantom. 18F-dPET experiments were performed using the phantom on a set of flow tubes representing large arteries, such as the aorta (1” 2.54 cm ID), down to smaller vessels, such as the iliac arteries and veins (1/4” 0.635 cm ID). When applied to the dPET experimental images, the PVE correction equations were able to successfully correct the image-derived input functions by as much as 59 ± 35% in the presence of background, which resulted in image-derived area under the curve (AUC) values within 8 ± 9% of ground truth AUC. The peak heights were similarly well corrected to within 9 ± 10% of the scaled DCE-CT curves. The same equations were then successfully applied to correct patient input functions in the aorta and internal iliac artery/vein. These straightforward algorithms can be applied to dPET images from any PET-CT scanner to restore the input function back to a more clinically representative value, without the need for high-end Time of Flight systems or Point Spread Function correction algorithms.

1. Introduction

The vast majority of Positron Emission Tomography (PET) studies involve the imaging of static, late whole-body images, which are typically done between 60 [1,2,3,4,5,6] and 90 [2,3,4,5,7] minutes post injection. These scans produce images which can be converted to units of SUV (Standardized Uptake Value), based on the injected radiotracer dose, half-life, time from injection and patient weight. The SUV values of a region of interest (ROI), especially noise-dependent values, such as the max SUV (SUVmax), are dependent on a wide range of factors (scanner calibration, reconstruction algorithm, frame duration, scatter correction, presence of Time of Flight capability, etc.) and can be difficult to compare between systems and institutions [1,5]. More importantly, the SUV of a static scan is a snapshot of the underlying dynamic processes, which, as a whole, may provide a wealth of information about a patient’s underlying physiology.
One intrinsic benefit of PET is that the dynamic imaging (i.e., imaging the patient continuously) can be performed over the course of minutes and up to an hour, without additional radiation dose to the patient. Kinetic modeling with dynamic imaging data can help describe important physiologic processes, such as regional blood flow, glucose metabolism or receptor density [1,2,3,4,5,8,9]. Although dynamic PET (dPET) imaging is increasingly applied with different radiotracers to measure various organs or disease physiology, it has not reached widespread clinical usage [1,6].
The review article by Dimitrakopoulou-Strauss et al. (2021) [1] performed a detailed literature search of over 130 papers on compartment modelling in dPET, with the most commonly used tracer being a glucose analog,18F-FDG (n = 42). Over 30 different radiotracers have been investigated within this volume of work, including agents aimed at binding to receptors over-expressed on certain cancer cells, such as 18F-PSMA or 68Ga-PSMA and 68Ga-DOTA [10,11,12,13,14,15], while other radiotracers assess other metabolic processes, such as hypoxia, using 18F-FMISO, 18F-FAZA or 18F-HX-4 [16,17,18,19,20,21,22].
To perform quantitative studies using dPET, some form of mathematical model describing the radioligand kinetics is required [1,5,8,9]. Typically, these kinetic models include an “arterial input function” (AIF), representing the image- or population-derived amount of tracer in the arterial blood, leading to an ROI (i.e., a function of time) and the ‘‘time activity curve’’ (TAC), which is the image-derived radioactivity in the tissue ROI over time. These two sets of data are acquired during the dynamic acquisition, and they are fitted into the kinetic model to estimate the associated model parameters.
Unfortunately, the limited axial field of view (FOV) of standard PET-CT scanners is typically in the range of 15–20 cm, which precludes measuring multiple target lesions at once. This small FOV also prevents the sampling of an arterial input function from a large artery, such as the aorta (ID > 2 cm), when the lesion or organ of interest is located outside the thorax. As a result, the image-based input function for kinetic models often must be sampled using much smaller (ID < 1 cm) arteries (internal carotid for brain, internal iliac for prostate, rectum or cervix).
This limitation results in challenges in performing kinetic modelling, because in order to obtain accurate kinetic model parameters, the input function must not be affected by partial volume effects [1,5]. Partial volume effects (PVE) in PET occur as a result of the low spatial resolution of PET imaging (4–6 mm) [5]. As a result of the limited spatial resolution, small objects can have much of their activity “spilled-out” of the actual region (Figure 1), such that the mean activity of the contoured region is underestimated. When the objects are sufficiently small (<2–3 times the spatial resolution of the system, which is typically 4–7 mm), even the SUVmax may be significantly reduced [6]. Unfortunately, small vessels, such as the internal iliac or femoral artery, typically have diameters between 5 and 8 mm, which leads to their image-derived AIF being substantially reduced, causing inaccuracies in kinetic modelling results.
A number of correction strategies have attempted to address PVE of AIF in dPET. The most common approach applies the use of recovery coefficients, which is a typical approach applied in static PET scans. This approach involves performing a relative correction, using a constant for a region based on its true size [1,5,23,24,25,26,27]. These approaches are primarily designed for spherical lesions and intended to correct only the SUVmax (a measurement of 1 voxel) of a region of interest, leaving the SUVmean unaccounted for. Unfortunately, the SUVmax is more sensitive to statistical fluctuations, especially in situations with very high PET noise [5,28]. High noise is the norm in dPET, where frame duration can be as low as 10 s, and this often leads to an overestimation of the true value [28]. Another challenge to these approaches corrects only for the “spill-out” from the ROI, while neglecting the “spill-in” from other regions into the ROI, from either the background or another high-activity region (veins, bladder, etc.).
Many modern PET-CT systems also include point-spread function (PSF) correction algorithms, which have been applied to correct AIF [29] in dynamic studies. These PSF algorithms attempt to computationally correct the SUVmax of lesions via iterative deconvolution approaches. These approaches occur right on the system, so they are easy to perform; however, they often result in overcorrection [30] and, as in the case of recovery coefficients, really only work at correcting the noise-dependent SUVmax term [28].
In a properly calibrated PET-CT scanner, the total activity should always be accounted for somewhere in the image field of view (FOV), such that even when there are partial volume effects, the cumulative activity in the image is still correct [5,31]. In simplified terms, the observed signal in an ROI is made up of the actual activity minus the “spill-out” to other regions, plus the “spill-in” from other neighbouring regions to the ROI. The use of recovery coefficients is based on this theory and utilizes a set of known coefficients, derived from spherical phantom measurements, to determine the true activity for a sphere, based on the measured activity and the volume of the sphere. In this manuscript, we propose a straightforward approach, based on the conservation of activity, to account for the activity “spilled-in” to an ROI from the background, as well as that “spilled-out” of the ROI.
Though simple, this approach involves different equations for different scenarios that need thorough validation before they can be utilized for AIF correction in patient studies [32]. To validate these correction equations, a phantom was designed and constructed with the capability of generating a set of input functions on different diameter tubes but maintaining the input function shape (both peak intensity and area under curve, AUC).

2. Methods

2.1. Partial Volume Effect Correction via Conservation of Activity

We propose a numerical approach, based on the conservation of activity (CoA), to correct the mean activity in a region by adding all the activity in a larger region which includes the “spill-out” and dividing by the true volume as shown in Equation (1).
C A   C o r r = C S O V S O V A
In this equation CA Corr represents the corrected activity (CA) in Bq/cc in the defined tube/artery region VA (in cubic centimeters (cc)) while CA is the image-derived activity if simply reporting the mean activity within VA without correction. VA can be accurately measured on the CT image for a PET-CT scanner. This CA Corr value is obtained by multiplying the larger mean activity of the tube region which includes the “spill-out” (CSO) by the larger volume (VSO) then dividing by the true tube/artery volume (VA). Note that CSO and VSO encompass the CA and VA respectively. VSO is also assumed to be large enough to ‘contain’ all the ‘spill-out’ signal from tube.
This simple approach in Equation (1) only works in regions where the background concentration is zero. As observed in clinical scans, there is always a low level of residual activity throughout the patient even after a few hours post radiotracer injection. In order to incorporate background into Equation (1), we assume the region outside VA but within VSO is filled with background activity in addition to ‘spill-out’ signal from the VA as displayed in Figure 2. Therefore, the measured activity in VA will require subtraction of background activity in the annulus region of VSO to correctly capture the ‘spill-out’ signal.
C A   C o r r = C S O V S O C B K G ( V S O V A ) V A
where CBKG is the concentration in annulus region between the blue and green circle in Figure 2. Its location is assumed to be far enough from any ‘spill-out’ signal from the tube and therefore CBKG represents the ‘true’ background concentration. It is also assumed that the amount of “spill-in” from the background to VSO is equal to the “spill-out” from VSO to the background which should be true provided VSO is sufficiently large.
In situations where there are other vessels in the region of the AIF, such as the case of the internal iliac artery and veins, additional corrections and assumptions are required. In this scenario, depicted in Figure 3, both the artery and vein contribute to the activity in VSO.
In order to address this combined influence on the cumulative activity in the “spill-out” we can include both the CA CORR and CV CORR terms in the activity balance and make sure we also subtract the area of both vein VV and artery VA from the background contribution. We need to make another assumption that the contribution of the total activity in the artery and vein are proportional to the image-derived signal CAVA and CVVV. Making those assumptions leads to the derivation of Equation (6) below.
C A   C o r r V A + C V   C o r r V V = C S O V S O C B K G ( V S O V A V V )
Assume:
C A   C o r r V A C V   C o r r V V = C A V A C V V V
Sub B into A:
C A   C o r r V A + C A   C o r r V A C V V V C A V A = C S O V S O C B K G ( V S O V A V V )
C A   C o r r = C S O V S O C B K G ( V S O V A V V ) V A × C A V A C A V A + C V V V

2.2. Phantom Design

To test and validate PVE correction models for dynamic PET-CT, we required a phantom capable of creating an identical input function across multiple tube diameters (Figure 4). The phantom was created with a flow system similar in design to that of Driscoll et al. [33] but the perfusion chamber was replaced with the novel phantom shell and tubes to serve as background and hot regions, respectively.
This phantom contained a water-tight shell as well as a set of 4 tubes of decreasing diameter from 1” (25.4 mm) to 1/4” (6.35 mm). The choice of these tube sizes was to resemble the size of descending aorta (1”) to that of the internal iliac arteries [5] which are typically used as the AIF for numerous perfusion sites including cervix, prostate and rectum. The 1/4” tube then left the phantom and was diluted with a buffer compartment before re-entering the phantom to simulate venous flow from the iliac vein.
In addition to the input function tubes, a flow system was attached to fill and inject contrast/radioisotope into the background compartment. Flow @ 10 mL/s was perfused through the tubes using a peristaltic pump (Fisher Scientific, Hampton, NH, USA) with control valves allowing for flow through the tubes, background or both simultaneously.

2.3. Experimental Setup and Validation in CT

To establish reference ‘input function’ curves with consistent peak activity and AUC, dynamic contrast enhanced (DCE)-CT Scanning was performed with a 1 s Gantry rotation 120 kV, 350 mA every 6 s for 4 min on a GE Discovery 610 PET-CT system.
The phantom was set up on the CT couch as shown in Figure 4. A Harvard Syringe Injection Pump was attached to the system and connected to each of the two mixing chambers, one for the input function and one for background. A 60 cc syringe was loaded with a 1:1 mixture of 370 mgI/mL Iodine based contrast agent and water. The flow rate through the system was set to 600 mL/min. Injection of the contrast agent occurred at 0.5 mL/s for 50 s. A replicate experiment was performed to produce error bars (range of measurements n = 2).

2.4. PET-CT Experiments

Every attempt was made to ensure that the PET-CT protocol generated identical time activity curves to the DCE-CT scan. The same setup was utilized for the PET-CT experiments with the only difference being that instead of a 1:1 mix of 370 mgI/mL contrast, we used 88 MBq 18F-FDG diluted in 100 cc water. From the 18F-FDG dilution, 60 cc (53 MBq) was loaded into a syringe to be injected @ 0.5 mL/s for 50 s as in DCE-CT. For the background compartment, a separate syringe was loaded with 30 MBq 18F-FDG diluted in water.
Two PET-CT experiments were performed; one with background and one without. Background 18F-FDG was injected through the second mixing chamber between the first and second experiment providing physiologically relevant background level of 1.35 kBq/cc.
Dynamic PET-CT was acquired in 15 × 20 s bins on the same GE Discovery 610 system (256 × 256 matrix size 3.27 mm slice thickness). This system does not have Time of Flight capability and no point spread function-based corrections were applied to the images. The area under the curve (AUC) of the PET-CT experiments was calculated based on the sum of the mean ROI activity at each time point, multiplied by the bin width (20 s), for units of kBq x s/cc. The ground truth AUC for comparison is based on the known injected activity of the PET-CT injected over the 50 s period and decay corrected to the time of experiment. Attenuation correction for the dynamic PET was based on a single low-dose static CT taken prior to radioisotope injection.

2.5. Image Analysis and Partial Volume Correction

DICOM images were analyzed in MIM 6.8.6 (MIM Software Inc., Cleveland, OH, USA) where 3D cylindrical ROIs were placed along the length of the tubes at the actual tube size (with activity CA). A second region (with activity CSO) was created with a radius 1.5 cm larger than VA. For scans with background an additional region (with activity CBkg) was added as a ring with inner radius the same as CSO and outer radius 1 cm larger (Figure 3). For the 1/4” vein and artery tubes, a combined CSO region was contoured using a 2 cm diameter cylinder encompassing both tubes and their “spill-out”. Due to the relative complexity of the scan, only the two experiments were performed, however, multiple ROIs (n = 5) were created along the tube with similar axial dimensions (2 cm each) to the amount of straight internal iliac artery available. Error bars were derived from these measurements (±Standard Error n = 5).
In order to directly compare PET-CT and DCE-CT curves on the same graph in terms of shape and magnitude, it is necessary to establish conversion units for PET-CT and DCE-CT. Unit of HU can be converted to mgI/mL by dividing the contrast to enhancement ratio of 23 HU/mgI/mL @ 120 kVp based on a contrast calibration phantom scan. Based on this conversion factor and the total injected amount of 18F (22 MBq) and iodine (4625 mg), a ratio of 4.8 HU/kBq/cc was obtained and applied to scale the PET-CT and DEC-CT curves for plotting on the same graph.

2.6. Application of the Input Function Correction Model to Sample Patient Image Sets

dPET DICOM images from two patients were obtained as part of two separate REB-approved research studies (NCT02701699 and NCT01567800) using 18F-FAZA. Informed consent was obtained as part of study recruitment for both patients. One scan involved a 20 min dynamic scan of the thorax of a patient of which the aorta was measured while an additional patient had a 20 min dynamic scan of their prostate in which the internal iliac artery and vein could be measured. In the first case Equation (2) was applied to the aorta and in the second case Equation (6) was applied to the artery and vein.

3. Results

3.1. DCE-CT Results and Validation

Due to the design of the phantom, with the size of the tubes shrinking from 1” down to 1/4” ID, neither the peak intensity nor shape of the input functions were expected to change from tube to tube. As the fluid moves through the system, the velocity increases but the volumetric flow rate remains constant. As a result, the reference curves generated maintained the same peak height, shape and AUC (Figure 5). The peak intensities of all 4 curves were within 0.6% of the group mean, while the curve AUCs were within 1.6% of the group mean.
For all intents and purposes, the DCE-CT curves sampled the input curves instantaneously, while the dPET scans were done with a 20 s bin time. Therefore, the ‘instantaneous’ CT curves were averaged with the same temporal scheme as the dPET scan to produce a set of averaged DEC-CT curves (dashed lines in Figure 5), as a reference for comparison in subsequent figures.

3.2. PET-CT Results and Corrections—Without Background

A dynamic PET-CT scan was performed using the same injection and flow parameters as for DCE-CT, except substituting 18F-FDG for contrast. No radioactivity was injected into the background compartment in this experiment. As observed in Figure 6 (solid lines), significant PVE is evident, and the measured peak activity becomes progressively depressed as the tube size becomes smaller. Only the largest three tubes are displayed in Figure 6, as the presence of the neighbouring 1/4” venous flow tube requires correction with Equation (6) (see Section 3.4). By applying Equation (1), we can correct the PVE by assigning all the “spill-out” activity in the regions surrounding the tube to the tube itself.
The correction equation results in an absolute increase in the AUC of 21 ± 3%, 39 ± 4% and 42 ± 4% for the 1”, 1/2” and 3/8” tubes, respectively. All quantitative results for all the validation studies are summarized in Table 1.

3.3. PET-CT Results and Corrections (with Background)

The same experiment as in Section 3.2 was repeated after 30 MBq of activity was injected into the background compartment. This provided a background activity of 1.4 kBq/cc, which is comparable to typically observed background concentrations in our dPET research scans in patients. Similar to Figure 6, Figure 7 (solid lines) shows that PVE becomes more evident as the tube size decreases.
In this case, Equation (2) must be applied to correct the input functions to more representative values, due to the presence of background. As in Figure 6, these corrected curves (Figure 7 dashed lines) are brought roughly in line with each other as the AUCs are recovered by 21 ± 4%, 38 ± 9% and 49 ± 15% for the 1”, 1/2” and 3/8” tubes, respectively.
When comparing the PET-CT curves (Figure 6 and Figure 7) to the predicted DCE-CT curves from Figure 5, we observe good alignment in both shape and intensity for the three curves (Figure 8). The CT and PET axis are adjusted based on a calculated scaling factor of 4.8 HU/kBq/cc.
By comparing the ground truth AUC with the image-derived AUC for the corrected PET-CTs, we observe a very good agreement, overall, for the three tubes in the presence of background (Figure 9 dotted lines), having calculated AUC within 5 ± 3%, 8 ± 9% and 6 ± 14% of ground truth for the 1”,1/2” and 3/8” tubes, respectively. The peak heights in the presence of background were similarly accurate with values within 6 ± 2% (1”), 8 ± 5% (1/2”) and 9 ± 7% (3/8”) of the averaged DCE-CT curves. In the absence of background, the tubes are all somewhat less corrected in terms of AUC, 12 ± 2% (1”), 13 ± 3% (1/2”) and 22 ± 3% (3/8”). Under those conditions, the errors after correction in the peak heights, 9 ± 1% (1”), 2 ± 11% (1/2”) and 1 ± 12% (3/8”) are all relatively low.

3.4. PET-CT Results Corrections for Artery/Vein in Close Proximity

The previous Section 3.2 and Section 3.3 discussed only the 1”, 1/2” and 3/8” tubes due to the fact that the 1/4” input tube also contains a companion 1/4” venous flow tube. Due to this fact, using Equation 2 leads to an extreme overcorrection of the input function (Figure 9) in AUC of 139 ± 7% in cases with background and 152 ± 31% in cases without. This overcorrection occurs as a result of additional signal in the CSO/VSO region coming from the venous tube, as well as the arterial tube. To account for this effect, Equation (6) must be employed instead in this scenario.
Using Equation (6) to address both the venous and arterial contributions to the “spill-out” region results in curves with AUC values within 13 ± 4% of the ground truth without background and 1 ± 17% with background. Similarly, the peak heights of the corrected 1/4” tubes are within 7 ± 5% of DCE-CT without background and 9 ± 10% with it. This is summarized in Table 1 and the results demonstrate that for all tube sizes down to 1/4”, and even in the presence of an alternative dynamic signal, it is possible to substantially correct the PVE in the small tube.

3.5. Application to Patient Scans

We applied the correction models to two patient dPET studies. Equation (2) was applied to the aorta (imaged ID 2.4 cm) of a patient undergoing dynamic PET-CT for a 18F-FAZA scan of the thorax, while Equation (6) was applied to correct the AIF from the internal iliac artery (IIA) (imaged ID 0.8 cm) in a prostate cancer 18F-FAZA PET-CT scan. Results of these corrections are displayed in Figure 10 (dashed lines).
As expected, the aorta correction was more moderate than the IIA, with a relative increase in AUC for the SUVmean of only 25%, while the corrected IIA had an increase of over 150%.

4. Discussion

There are a number of PVE correction strategies available on modern PET-CT systems or their companion analysis workstations. Many of these correction strategies focus on producing an accurate SUVmax measurement for lesions, which can be reported and used to determine if a tumour is metabolically active or not. However, readings such as the SUVmax, are strongly impacted by noise, due to the selection of only a single voxel [6,28]. This is especially problematic when performing dPET, as there is an inherent trade-off between signal to noise ratio and temporal resolution. In situations where kinetic modelling is to be utilized, the temporal resolution is critical, as setting the frame duration too long will result in decreased peak intensity and a flattened AIF. As such, frame times of 5–20 s are common, and this results in much noisier images than those observed in standard static PET, which have frame durations ranging from 2 to 5 min.
We have developed a relatively simple set of equations to correct for the PVE of AIF. The conservation of activity (CoA) correction method can be applied to any scanner, without the need for time of flight capability or built-in PSF correction algorithms. As the method only requires the ‘true’ geometry of the arterial region and dPET images, it is expected to work for PET-MR as well.
Other methods of PVE correction, such as those relying on recovery coefficients, will apply a linear correction to the ROI, based solely on size and regardless of the relative intensity of the background region and tube [1,6,23,24,25,26,27]. This may result in an AIF with a misrepresentative shape. Recovery coefficient (RC) -based methods are also incapable of dealing with situations involving multiple dynamic signals, as in the case of the internal iliac artery and vein. Figure 11a demonstrates a comparison between using a recovery co-efficient-based approach [23] (dashed line) and our CoA approach (dotted line) in the presence of background. Though the peak activity is recovered effectively using the RC method, once the activity in the tubes drops below background levels, the effect of PVE is reversed, leading to artificially increased activity levels. This is visualized in the last three points in the figure, where the CoA approach follows the DCE-CT scaled result, while the RC-based curve remains artificially increased.
18-FDG is much more accessible than 18-FAZA, which must be specially ordered. The use of 18-FDG or 18-FAZA is not expected to make a difference in the phantom scans, as both isotopes are 18-F based. The background concentration in the phantom (for our experiment with background) was selected based on the range of background tissue uptake at 60 min, observed in clinical studies with 18-FDG and 18-FAZA, according to our experience.
There is an inherent trade-off between signal to noise ratio and spatial resolution in PET imaging. It is interesting to see the effect of aliasing, as a result of 20 s frame duration, especially evident for the 3/8” tube. It is also interesting that the averaging of DCE-CT curves was able to predict the dPET curves with aliasing, accurately, when the dPET timing scheme was used. The averaged DCE-CT curves were chosen to be a reference for comparison with the corrected dPET curves. These two sets of curves matched very well in terms of shape and magnitude. The effect of the aliased AIF (as opposed to the ‘true’ AIF) on the accuracy of kinetic modeling is beyond the scope of this paper.
As seen in Figure 8 and Table 1, the correction of the AIF is equally successful in conditions of background and without, when assessed by peak height. However, the correction in the non-clinical conditions, without background, do not appear to sufficiently correct for the full signal loss due to PVE. When examining the dashed line in Figure 8c, in particular, and to a lesser degree, Figure 8b, it appears that the points at the tail end of the curve are mostly to blame for the reduction in AUC. These points occur at a time when the AIF is well below 5 kBq/cc and, as they are not similarly underestimated in the presence of background, might be due to limitation of PET reconstruction for extremely low total counts.
In order for the assumption that the background contribution to the annulus of CSO is represented by CBKG, it is important that the background region be sampled close to the “spill-out” region, but far enough not to be affected by the “spill-out”. Due to the constraint of fitting all five tubes in the PET-CT FOV, the tubes were placed about 2.5 inches (6.35 cm) apart. This physical limitation restricts how big the ROIs can be drawn around each tube before they start to encounter signal from neighbouring tubes. As a result, the background regions may include some minor “spill-out” from a neighbouring tube, which is not captured in the model. The impact of this in these experiments is an overestimation of the background signal, which leads to an underestimation of the AUC and peak of the CACORR. This particular constraint did not occur in the patient examples. However, care should be taken when selecting the background region to avoid unaccounted areas of enhancement, contributed by nearby lesions or vessels.
The proposed AIF correction method was applied to dPET studies of the thorax and pelvic area. As the two patient cases are of different patients, the results cannot be directly compared. However, the relative magnitudes of correction for aorta and IIA are 25% and 150%, respectively, similar to those in the phantom experiment for 1” and ¼” tubings. In addition, the corrected AIFs for the two cases have similar absolute magnitude, which is not unexpected for a fixed injection amount of radiotracer per patient weight. In both scenarios, the relative partial volume corrections of 25% and 150% to the aorta and IIA, respectively, are similar in impact to the phantom validation scans. It is also noted that the shape of the function is generally maintained, with the IIA taking on the classic arterial blood input function shape.
Figure 11b demonstrates the difference between an RC-based correction of the AIF and our CoA-based approach. As in the phantom example, Figure 11a, once the activity in the AIF decreases below background levels, the RC-based approach tends to artificially overestimate the AIF, leading to curves, which might misrepresent the true physiology. In this example, the RC correction-based AIF (dashed line) continues to depict an activity greater than the prostate lesion for the duration of the scan, while the CoA-based approach (dotted line) drops back below tumour levels by about 800 s.
This is especially critical when performing kinetic modeling, as the shape of the input function is nearly as important as the absolute peak intensity in determining the model parameters [8,9,11]. Using the three AIFs and segmented tumour from the FAZA-Prostate patient example, shown in Figure 11b, an irreversible 2-tissue compartment model was fitted to the curves (PMOD software v3.5), with results displayed in Table 2. In this model, K1 represents the flow into a diffusive compartment, while K2 represents the reverse flow back to the bloodstream. K3 represents the flow into the accumulative compartment, which, in the case of FAZA, represents hypoxic regions.
Both the RC and CoA-corrected AIF result in a dramatic reduction of K1 (73.2% for RC and 70.6% for CoA) and K2 (43.0% for RC and 36.2% for CoA) when compared to the uncorrected AIF, as a result of the increased ratio between the magnitude of AIF and Tumour curves, and the remarkable difference in K3 highlights the advantage of the CoA-based correction over the RC method. Since the tail of the AIF curve always remains above the tumour curve, the model predicts a K3 of 0 for the RC-corrected AIF. Conversely, the model actually predicts a much larger K3 (363%) value for the CoA-based approach, suggesting an increase in hypoxia, as compared to the result when using the uncorrected AIF.
Though these results are promising with limited sample size, further investigation is required to validate the use of this method in patient studies.

5. Conclusions

We have presented a method for PVE correction for AIF in dPET, without the need for complicated PSF algorithms or advanced hardware. Our approach allows even dated systems without time-of-flight capability to perform dPET, and it is expected to produce improved quantitative results in kinetic models. The proposed method is less sensitive to noise compared to other PVE correction methods, as it uses much less sensitive SUVmean-based measurements. These equations were validated by a phantom and shown to be useful at correcting even 1/4” tubes by as much as 59 ± 35%; the correction leads to values within 8 ± 9% of the predicted values in the presence of background activity, in terms of AUC. The peak heights were similarly well corrected to within 9 ± 10% of the averaged DCE-CT.
We also demonstrated that the method can be applied to patient data, to generate more representative input functions for kinetic modelling of dynamic PET datasets.

Author Contributions

B.D.: Investigation, Data curation, Formal analysis, Writing—original draft, Writing—review and editing. D.V.: Resources, Writing—review and editing. T.S.: Writing—review and editing, Validation. A.S.—Resources, D.J.: Funding acquisition. I.Y.: Methodology, Supervision, Writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

Funding was provided to the QIPCM Imaging Core lab by the Ontario Institute for Cancer Research and Princess Margaret Cancer Centre Foundation. The work was also partly supported by the Quantitative Imaging Network grant, funded by the Canadian Institute of Health Research (FRN 137992).

Institutional Review Board Statement

All patient data was obtained in accordance with HIPPA guidelines and after obtaining informed written consent according to guidelines approved by our. Institutional Review Board (IRB).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The phantom images created as part of this study will be made freely available upon publication.

Acknowledgments

Thank you to Michael Milosevic for his support as the PI for the FAZA Prostate study (NCT01567800).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dimitrakopoulou-Strauss, A.; Pan, L.; Sachpekidis, C. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur. J. Nucl. Med. Mol. Imaging 2021, 48, 21–39. [Google Scholar] [CrossRef] [PubMed]
  2. Sokoloff, L.; Reivich, M.; Kennedy, C.; Des Rosiers, M.H.; Patlak, C.S.; Pettigrew, K.D.; Sakurada, O.; Shinohara, M. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anerstized albino rat. J. Neurochem. 1977, 28, 897–916. [Google Scholar] [CrossRef] [PubMed]
  3. Wienhard, K. Measurements of glucose consumption using [18F)fluorodeoxyglucose. Methods 2002, 27, 218–225. [Google Scholar] [CrossRef]
  4. Tomasi, G.; Turkheimer, F.; Aboagye, E. Importance of quantification for the analysis of PET data in oncology: Review of current methods and trends for the future. Mol. Imaging Biol. 2012, 4, 131–146. [Google Scholar] [CrossRef]
  5. Bettinardi, V.; Castiglioni, I.; De Bernardi, E.; Gilardi, M.C. PET quantification: Strategies for partial volume correction. Clin. Transl. Imaging 2014, 2, 199–218. [Google Scholar] [CrossRef]
  6. Vallabhajosula, S.; Solnes, L.; Vallabhajosula, B. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: What is new? Semin. Nucl. Med. 2014, 41, 246–264. [Google Scholar] [CrossRef]
  7. Phelps, M.E.; Huang, S.C.; Hoffman, E.J.; Selin, C.; Sokoloff, L.; Kuhl, D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-glucose: Validation of methos. Ann. Neurol. 1979, 6, 371–388. [Google Scholar] [CrossRef]
  8. Carson, R.E. Tracer kinetic modeling in PET. In Positron Emission Tomography: Basic Science and Clinical Practice; Valk, P.E., Bailey, D.L., Townsend, D.W., Maisey, M.N., Eds.; Springer: London, UK, 2003; Chapter 6; Volume 78, pp. 147–179. [Google Scholar]
  9. Bentourkia, M.; Zaidi, H. Positron emission tomography. Tracer kinetic modeling in PET. PET Clin. 2007, 2, 267–277. [Google Scholar] [CrossRef]
  10. Sachpekidis, C.; Eder, M.; Kopka, K.; Mier, W.; Hadaschik, B.A.; Haberkorn, U.; Dimitrakopoulou-Strauss, A. 68Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 2016, 43, 1288–1299. [Google Scholar] [CrossRef]
  11. Koukouraki, S.; Strauss, L.G.; Georgoulias, V.; Eisenhut, M.; Haberkorn, U.; Dimitrakopoulou-Strauss, A. Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F] FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 1115–1120. [Google Scholar] [CrossRef]
  12. Henze, M.; Dimitrakopoulou-Strauss, A.; Milker-Zabel, S.; Schuhmacher, J.; Strauss, L.G.; Doll, J.; Mäcke, H.R.; Eisenhut, M.; Debus, J.; Haberkorn, U. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas. J. Nucl. Med. 2005, 46, 763–769. [Google Scholar] [PubMed]
  13. Ilan, E.; Sandström, M.; Velikyan, I.; Sundin, A.; Eriksson, B.; Lubberink, M. Parametric net imflux rate images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative accuracy and improved image contrast. J. Nucl. Med. 2017, 58, 744–749. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Sachpekidis, C.; Afshar-Oromieh, A.; Kopka, K.; Strauss, D.S.; Pan, L.; Haberkorn, U.; Dimitrakopoulou-Strauss, A. 18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 2019, 10, 1007. [Google Scholar] [CrossRef] [PubMed]
  15. Schmuck, S.; Mamach, M.; Wilke, F.; von Klot, C.A.; Henkenberens, C.; Thackeray, J.T.; Sohns, J.M.; Geworski, L.; Ross, T.L.; Wester, H.J.; et al. Multiple time-point 68Ga-PSMA I&T PET/CT for characterization of primary prostate Cancer: Value of early dynamic and delayed imaging. Clin. Nucl. Med. 2017, 42, 286–293. [Google Scholar]
  16. Koopman, T.; Verburg, N.; Pouwels, P.J.; Wesseling, P.; Hoekstra, O.S.; De Witt Hamer, P.C.; Lammertsma, A.A.; Yaqub, M.; Wesseling, P. Quantitative parametric maps of O-(2-(18F)fluoroethyl)-L-tyrosine kinetics in diffuse gliomas. J. Cereb. Blood Flow Metab. 2020, 40, 895–903. [Google Scholar] [CrossRef] [Green Version]
  17. Kudomi, N.; Maeda, Y.; Hatakeyama, T.; Yamamoto, Y.; Nishiyama, Y. Fully parametric imaging with reversible tracer 18F-FLT within a reasonable time. Radiol. Phys. Technol. 2017, 10, 41–48. [Google Scholar] [CrossRef]
  18. Sachpekidis, C.; Thieke, C.; Askoxylakis, V.; Nicolay, N.H.; Huber, P.E.; Thomas, M.; Dimitrakopoulou, G.; Debus, J.; Haberkorn, U.; Dimitrakopoulou-Strauss, A. Combined use of 18F-FDG and 18F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: A dynamic PET/CT study. Am. J. Nucl. Med. Mol. Imaging 2015, 5, 127–142. [Google Scholar]
  19. Schwartz, J.; Grkovski, M.; Rimner, A.; Schroeder, H.; Zanzonico, P.B.; Carlin, S.D.; Staton, K.D.; Humm, J.L.; Nehmeh, S.A. Pharmacokinetic analysis of dynamic 18F-Fluoromisonidazole PET data in non-small cell lung cancer. J. Nucl. Med. 2017, 58, 911–919. [Google Scholar] [CrossRef] [Green Version]
  20. Grkovski, M.; Lee, N.Y.; Schroeder, H.; Carlin, S.D.; Beattie, B.J.; Riaz, N.; Leeman, J.E.; O’Donoghue, J.A.; Humm, J.L. Monitoring early response to chemoradiotherapy with 18F-MISO dynamic PET in head and neck cancer. Eur. J. Nucl. Med. Mol. Imaging 2017, 44, 1682–1691. [Google Scholar] [CrossRef]
  21. Michaud, L.; Beattie, B.J.; Akhurst, T.; Dunphy, M.; Zanzonico, P.; Finn, R.; Mauguen, A.; Schöder, H.; Weber, W.A.; Lassman, A.B.; et al. 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors. Eur. J. Nucl. Med. Mol. Imaging 2019, 10, 1007. [Google Scholar]
  22. Verwer, E.E.; Zegers, C.M.; van Elmpt, W.; Wierts, R.; Windhorst, A.D.; Mottaghy, F.M.; Lambin, P.; Boellaard, R. Pharmacokinetic modeling of a novel hypoxia PET tracer [18F]HX4 in patients with non-small cell lung cancer. EJNMMI Phys. 2016, 3, 30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Feng, S.T.; Cui, M.; Gao, J.; Wu, B.; Sha, W.; Huang, B. Image-derived arterial input function in dynamic positron emission tomography-computed tomography: A method using both positron emission tomographic and computed tomographic images. J. Comput. Assist. Tomogr. 2012, 36, 762–767. [Google Scholar] [CrossRef]
  24. Anazodo, U.; Kewin, M.; Finger, E.; Thiessen, J.; Hadway, J.; Butler, L.; Pavlosky, W.; Prato, F.; Thompson, T.; Lawrence, K.S. Preliminary evaluation of MRI-derived input function for quantitative measurement of glucose metabolism in an integrated PET-MRI. EJNMMI Phys. 2015, 2, A80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Muzi, M.; O’Sullivan, F.; Mankoff, D.A.; Doot, R.K.; Pierce, L.A.; Kurland, B.F.; Linden, H.M.; Kinahan, P.E. Quantitative assessment of dynamic PET imaging data in cancer imaging. Magn. Reson. Imaging 2012, 30, 1203–1215. [Google Scholar] [CrossRef] [Green Version]
  26. Litton, J.E. Input function in PET brain studies using MRdefined arteries. J. Comput. Assist. Tomogr. 1997, 21, 907–909. [Google Scholar] [CrossRef] [PubMed]
  27. Croteau, E.; Lavallée, E.; Labbe, S.M.; Hubert, L.; Pifferi, F.; Rousseau, J.A.; Cunnane, S.C.; Carpentier, A.C.; Lecomte, R.; Bénard, F. Image-derived input function in dynamic human PET/CT: Methodology and validation with 11C-acetate and 18F-fluorothioheptadecanoic acid in muscle and 18F-fluorodeoxyglucose in brain. Eur. J. Nucl. Med. Mol. Imaging 2010, 37, 1539–1550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Lodge, M.A.; Chaudhry, M.A.; Wahl, R.L. Noise considerations for PET quantification using maximum and peak standardized uptake value. J. Nucl. Med. 2012, 53, 1041–1047. [Google Scholar] [CrossRef] [Green Version]
  29. Mourik, J.E.; Lubberink, M.; Klumpers, U.M.; Comans, E.F.; Lammertsma, A.A.; Boellaard, R. Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C]flumazenil. Neuroimage 2008, 39, 1041–1050. [Google Scholar] [CrossRef]
  30. Cysouw, M.C.F.; Kramer, G.M.; Hoekstra, O.S.; Frings, V.; de Langen, A.J.; Smit, E.F.; van den Eertwegh, A.J.M.; Oprea-Lager, D.E.; Boellaard, R. Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies. J. Nucl. Med. 2016, 57, 1642–1649. [Google Scholar] [CrossRef] [Green Version]
  31. Chen, K.; Bandy, D.; Reiman, E.; Huang, S.C.; Lawson, M.; Feng, D.; Yun, L.S.; Palant, A. Non invasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J. Cereb. Blood Flow Metab. 1998, 18, 716–723. [Google Scholar] [CrossRef] [Green Version]
  32. Zanotti-Fregonara, P.; Chen, K.; Liow, J.S.; Fujita, M.; Innis, R.B. Image-derived input function for brain PET studies: Many challenges and few opportunities. J. Cereb. Blood Flow Metab. 2011, 31, 1986–1998. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Driscoll, B.; Keller, H.; Coolens, C. Development of a dynamic flow imaging phantom for dynamic contrast-enhanced CT. Med. Phys. 2011, 38, 4866–4880. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Visualization of PET PVE in the presented phantom, specifically the “spill-out” effect from the hot to cold region. (a) The true artery ROI (outlined in red) as contoured in CT is listed as having image-derived concentration CA and volume VA while the large region (labelled CSO/VSO, outlined in blue) is comprised of the true hot region plus the “spill-out” region. (b) Visualization of the “spill-out” from the VA region into VSO shown on the PET only.
Figure 1. Visualization of PET PVE in the presented phantom, specifically the “spill-out” effect from the hot to cold region. (a) The true artery ROI (outlined in red) as contoured in CT is listed as having image-derived concentration CA and volume VA while the large region (labelled CSO/VSO, outlined in blue) is comprised of the true hot region plus the “spill-out” region. (b) Visualization of the “spill-out” from the VA region into VSO shown on the PET only.
Tomography 08 00069 g001
Figure 2. Partial volume correction in the presence of background. (a) In addition to CA/VA and CSO/VSO an additional region outside of the “spill-out” region is selected as the background concentration CBKG is outlined in green. (b) Visualization of the “spill-out” from the VA region into VSO is still evident even in the presence of background shown on the PET only.
Figure 2. Partial volume correction in the presence of background. (a) In addition to CA/VA and CSO/VSO an additional region outside of the “spill-out” region is selected as the background concentration CBKG is outlined in green. (b) Visualization of the “spill-out” from the VA region into VSO is still evident even in the presence of background shown on the PET only.
Tomography 08 00069 g002
Figure 3. Partial volume correction in the presence of two signal functions. (a) In addition to the “spill-out” (CSO/VSO) and background activity (CBKG), the CA/VA terms for the arterial input as well as new terms CV/VV representing the venous function are separately outlined. (b) “Spill-out” from these small ¼” tubes is easily observable on the PET image.
Figure 3. Partial volume correction in the presence of two signal functions. (a) In addition to the “spill-out” (CSO/VSO) and background activity (CBKG), the CA/VA terms for the arterial input as well as new terms CV/VV representing the venous function are separately outlined. (b) “Spill-out” from these small ¼” tubes is easily observable on the PET image.
Tomography 08 00069 g003
Figure 4. The AIF Correction factor validation phantom. (a) The four tubes inside the phantom shell decreasing in size from 1” to 1/2”, 3/8” and finally 1/4” followed by the buffer tube at the right side. (b) The injection setup on the PET-CT couch. Scanning is performed in the middle of the tubes over a single (14.7 cm) PET field of view.
Figure 4. The AIF Correction factor validation phantom. (a) The four tubes inside the phantom shell decreasing in size from 1” to 1/2”, 3/8” and finally 1/4” followed by the buffer tube at the right side. (b) The injection setup on the PET-CT couch. Scanning is performed in the middle of the tubes over a single (14.7 cm) PET field of view.
Tomography 08 00069 g004
Figure 5. Solid lines are input function shape and intensity of the 4 tubes of decreasing internal diameter as assessed with DCE-CT. As the contrast passes through tubes of decreasing size the velocity of the fluid increases but the flow rate remains constant which produces a set of 4 reference curves with equal intensity, shape and AUC. Dashed lines are curves with averaging done over 20 s on the corresponding solid lines at the same sampling time points as the dPET scan (described in Section 3.2). Error bars represent the experimental range of replicate results (n = 2).
Figure 5. Solid lines are input function shape and intensity of the 4 tubes of decreasing internal diameter as assessed with DCE-CT. As the contrast passes through tubes of decreasing size the velocity of the fluid increases but the flow rate remains constant which produces a set of 4 reference curves with equal intensity, shape and AUC. Dashed lines are curves with averaging done over 20 s on the corresponding solid lines at the same sampling time points as the dPET scan (described in Section 3.2). Error bars represent the experimental range of replicate results (n = 2).
Tomography 08 00069 g005
Figure 6. Mean input function activity can be successfully corrected for flow tubes (a) 1” (25.4 mm), (b) ½” (12.7 mm) and (c) 3/8” (9.5 mm) in a situation with no background. All three tubes are corrected to varying degrees with smaller tubes having larger corrections (42 ± 4% for 3/8”) than the large ones (21 ± 3% for 1”) in terms of AUC Error bars represent the standard error from multiple ROI regions (n = 5).
Figure 6. Mean input function activity can be successfully corrected for flow tubes (a) 1” (25.4 mm), (b) ½” (12.7 mm) and (c) 3/8” (9.5 mm) in a situation with no background. All three tubes are corrected to varying degrees with smaller tubes having larger corrections (42 ± 4% for 3/8”) than the large ones (21 ± 3% for 1”) in terms of AUC Error bars represent the standard error from multiple ROI regions (n = 5).
Tomography 08 00069 g006
Figure 7. PVE in dPET Input functions at all tube sizes (a) 1” (25.4 mm), (b) ½” (12.7 mm) and (c) 3/8” (9.5 mm) can be substantially corrected even in conditions of background activity. The substantial PVE observed in the uncorrected (solid lines) input function can be corrected (dashed lines) by as much as 49 ± 15% for the 3/8” tube based on AUC. Error bars represent the standard error from multiple ROI regions (n = 5).
Figure 7. PVE in dPET Input functions at all tube sizes (a) 1” (25.4 mm), (b) ½” (12.7 mm) and (c) 3/8” (9.5 mm) can be substantially corrected even in conditions of background activity. The substantial PVE observed in the uncorrected (solid lines) input function can be corrected (dashed lines) by as much as 49 ± 15% for the 3/8” tube based on AUC. Error bars represent the standard error from multiple ROI regions (n = 5).
Tomography 08 00069 g007
Figure 8. Corrected input functions at all tube sizes (a) 1” (25.4 mm), (b) ½” (12.7 mm) and (c) 3/8” (9.5 mm) with (dotted) and without (dashed) background are restored to various degrees in terms of both peak height and AUC. In the presence of background all three tubes have calculated AUC within 8 ± 9% of ground truth and peak heights within 9 ± 7% of averaged DCE-CT. In the absence of background these values are all somewhat reduced. PET-CT error bars represent the standard error from multiple ROI regions (n = 5). CT error bars represent the experimental range of replicate experiments (n = 2).
Figure 8. Corrected input functions at all tube sizes (a) 1” (25.4 mm), (b) ½” (12.7 mm) and (c) 3/8” (9.5 mm) with (dotted) and without (dashed) background are restored to various degrees in terms of both peak height and AUC. In the presence of background all three tubes have calculated AUC within 8 ± 9% of ground truth and peak heights within 9 ± 7% of averaged DCE-CT. In the absence of background these values are all somewhat reduced. PET-CT error bars represent the standard error from multiple ROI regions (n = 5). CT error bars represent the experimental range of replicate experiments (n = 2).
Tomography 08 00069 g008
Figure 9. The overcorrection (open symbols) of the original input functions (filled circles) due to proximity of the venous tube when using Equation (2) (diamond symbols) can be corrected (Cor*) using Equation (6) (closed symbols) in both cases with and without background. PET-CT error bars represent the standard error from multiple ROI regions (n = 5). CT error bars represent the experimental range of replicate experiments (n = 2).
Figure 9. The overcorrection (open symbols) of the original input functions (filled circles) due to proximity of the venous tube when using Equation (2) (diamond symbols) can be corrected (Cor*) using Equation (6) (closed symbols) in both cases with and without background. PET-CT error bars represent the standard error from multiple ROI regions (n = 5). CT error bars represent the experimental range of replicate experiments (n = 2).
Tomography 08 00069 g009
Figure 10. AIF Correction equations were successfully utilized to correct large vessels such as the descending Aorta (a) as well as smaller vessels such as the internal iliac artery (b) which is affected by both PVE and the neighboring internal iliac vein.
Figure 10. AIF Correction equations were successfully utilized to correct large vessels such as the descending Aorta (a) as well as smaller vessels such as the internal iliac artery (b) which is affected by both PVE and the neighboring internal iliac vein.
Tomography 08 00069 g010
Figure 11. Correction of the AIF can be performed more accurately with the CoA based approach than with traditional recovery coefficient-based methods. (a) When applying a recovery coefficient-based correction the peak activity is recovered effectively; however, once the activity in the tubes drops below background levels, the effect of PVE is reversed leading to artificial increased activity levels. (b) This artificial increase in the AIF is apparent in patient scans where the RC-corrected AIF remains above tumour levels for the duration of the scan while the CoA method drops back below tumour levels around 800 s.
Figure 11. Correction of the AIF can be performed more accurately with the CoA based approach than with traditional recovery coefficient-based methods. (a) When applying a recovery coefficient-based correction the peak activity is recovered effectively; however, once the activity in the tubes drops below background levels, the effect of PVE is reversed leading to artificial increased activity levels. (b) This artificial increase in the AIF is apparent in patient scans where the RC-corrected AIF remains above tumour levels for the duration of the scan while the CoA method drops back below tumour levels around 800 s.
Tomography 08 00069 g011
Table 1. Quantitative Results of Input Function PVE correction. (All results are shown ± the standard error of the mean n = 5.)
Table 1. Quantitative Results of Input Function PVE correction. (All results are shown ± the standard error of the mean n = 5.)
1”
(25.4 mm)
Cor. 1”
(25.4 mm)
1/2”
(12.7 mm)
Cor. 1/2”
(12.7 mm)
3/8”
(9.5 mm)
Cor. 3/8”
(9.5 mm)
1/4”
(6.35 mm)
Cor. 1/4”
(6.35 mm)
No Background
AUC (kBq/cc × s)1399 ± 341827 ± 46977 ± 391783 ± 68747 ± 371610 ± 68573 ± 311807 ± 87
% Error vs. Model−33% ± 2%−12% ± 2%−53% ± 2%−14% ± 3%−64% ± 2%−22% ± 3%−72% ± 1%−13% ± 4%
% Improvement vs. uncorrected 21% ± 3% 39% ± 4% 42% ± 4% 60% ± 8%
With Background
AUC (kBq/cc × s)1535 ± 391975 ± 721104 ± 481902 ± 183941 ± 441950 ± 300828 ± 422056 ± 351
% Error vs. Model−26% ± 2%−5% ± 3%−47% ± 2%−8% ± 9%−55% ± 2%−6% ± 14%−60% ± 2%−1% ± 17%
% Improvement vs. uncorrected 21% ± 4% 38% ± 9% 49% ± 15% 59% ± 35%
Table 2. Effect of AIF correction on kinetic model parameters.
Table 2. Effect of AIF correction on kinetic model parameters.
K1
(mL/cc/min)
K2
(1/min)
K3
(1/min)
Original AIF0.13520.09650.0071
RC Corrected AIF0.03630.0550
CoA Corrected AIF0.03980.06160.0328
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Driscoll, B.; Shek, T.; Vines, D.; Sun, A.; Jaffray, D.; Yeung, I. Phantom Validation of a Conservation of Activity-Based Partial Volume Correction Method for Arterial Input Function in Dynamic PET Imaging. Tomography 2022, 8, 842-857. https://doi.org/10.3390/tomography8020069

AMA Style

Driscoll B, Shek T, Vines D, Sun A, Jaffray D, Yeung I. Phantom Validation of a Conservation of Activity-Based Partial Volume Correction Method for Arterial Input Function in Dynamic PET Imaging. Tomography. 2022; 8(2):842-857. https://doi.org/10.3390/tomography8020069

Chicago/Turabian Style

Driscoll, Brandon, Tina Shek, Douglass Vines, Alex Sun, David Jaffray, and Ivan Yeung. 2022. "Phantom Validation of a Conservation of Activity-Based Partial Volume Correction Method for Arterial Input Function in Dynamic PET Imaging" Tomography 8, no. 2: 842-857. https://doi.org/10.3390/tomography8020069

Article Metrics

Back to TopTop